70 Participants Needed

Adhesive-Based Sensors for Cancer-Related Lymphedema

TO
SH
Overseen ByShannon Hainline
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ohio State University Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This clinical trial studies how well new adhesive-based sensors that stick to the skin (transcutaneous) work in detecting cancer-related long-term arm swelling (lymphedema). For many patients, lymphedema s painful, unsightly, and weakening. The early signs of lymphedema are hard to see, and sometimes it is only diagnosed by hospital equipment at larger centers. Treating lymphedema early is usually more successful than trying to treat in later stages. The adhesive-based sensors used in this study work by using techniques called photoplethysmography (PPG) and bioimpedance (BI). PPG is an optical technique that can be used to detect blood volume changes in tissue. BI evaluates how tissue responds to an externally applied electrical current. This study may assist researchers in distinguishing participants with lymphedema in comparison to participants without lymphedema, and develop a way for patients to check for lymphedema at home.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are on endocrine monotherapy for breast cancer, you can continue with it while participating in the trial.

What data supports the effectiveness of adhesive-based sensors for detecting cancer-related lymphedema?

The research highlights the importance of technology in monitoring lymphedema, with nonwearable sensors being more developed for remote monitoring. Additionally, bioelectrical spectroscopy (BIS) has shown high reliability and validity in assessing limb fluid, suggesting that similar sensor technologies could be effective for lymphedema detection.12345

Is it safe to use adhesive-based sensors for monitoring lymphedema?

The research does not provide specific safety data for adhesive-based sensors, but it discusses the use of various technologies for monitoring lymphedema, suggesting that these technologies are generally considered safe for use in humans.12567

How does the adhesive-based sensor treatment for cancer-related lymphedema differ from other treatments?

The adhesive-based sensor treatment for cancer-related lymphedema is unique because it uses wearable sensors to non-invasively monitor the condition, providing real-time data on skin hydration and other physiological signals. This approach is different from traditional treatments that may not offer continuous monitoring or the ability to adapt to wet skin conditions.89101112

Research Team

CM

Carlo M. Contreras, MD

Principal Investigator

Ohio State University Comprehensive Cancer Center

Eligibility Criteria

This trial is for healthy individuals and those with pre-existing lymphedema due to cancer therapy involving surgery or radiation. Participants should have arm swelling needing compression or a significant size difference between arms. Active cancer patients, except breast cancer ones on endocrine monotherapy, can't join.

Inclusion Criteria

I had cancer treatment with surgery or radiation targeting the armpit area.
COHORT A: Healthy participants
COHORT B: Participants with pre-existing lymphedema
See 1 more

Exclusion Criteria

I am not receiving cancer treatment, except for hormone therapy for breast cancer.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Diagnostic Assessment

Participants undergo bioimpedance analysis (BIA) and wear 'watch-like' sensors for photoplethysmography (PPG) at rest and while active

Up to 2 hours
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness of the sensor technology

2-4 weeks

Treatment Details

Interventions

  • Transcutaneous Sensors
Trial OverviewThe study tests new skin-adhesive sensors that detect early signs of lymphedema using photoplethysmography (PPG) and bioimpedance (BI). PPG measures blood volume changes in tissue, while BI assesses tissue response to electrical currents. The goal is to help patients monitor lymphedema at home.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Diagnostic (BI, PPG)Experimental Treatment4 Interventions
Participants undergo BIA and wear "watch-like" sensors and undergo PPG at rest and while active (pedaling an exercise bike) on study.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University Comprehensive Cancer Center

Lead Sponsor

Trials
350
Recruited
295,000+

Findings from Research

The scoping review identified six studies that discussed various sensors for monitoring breast cancer-related lymphedema, highlighting a total of six different devices, both wearable and nonwearable.
Nonwearable sensors are currently more advanced and commercially available for remote lymphedema monitoring compared to wearable sensors, indicating a need for further development and validation in this area.
Development of Pressure Sensors to Help Support Community Lymphedema Monitoring: A Scoping Review.Rajab, O., Armstrong, E., Ferguson-Pell, M.[2023]
Breast cancer-related lymphedema (BCRL) affects about 20% of breast cancer patients, and early diagnosis through comprehensive screening can prevent its progression and improve quality of life.
The Massachusetts General Hospital's prospective screening program utilizes advanced technologies like perometry and bioimpedance spectroscopy, along with clinical assessments, to accurately diagnose and monitor BCRL, highlighting the importance of both objective and subjective data in patient care.
Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital.Havens, LM., Brunelle, CL., Gillespie, TC., et al.[2021]
In a study of 48 breast cancer patients with lymphedema, adding padding to multilayer inelastic bandaging significantly increased both resting and working pressures, enhancing the effectiveness of compression therapy.
Patients who received additional padding experienced a greater reduction in limb volume after 2 weeks of treatment, indicating that padding can improve outcomes in lymphedema management.
Pressure monitoring of multilayer inelastic bandaging and the effect of padding in breast cancer-related lymphedema patients.Kang, Y., Jang, DH., Jeon, JY., et al.[2019]

References

Development of Pressure Sensors to Help Support Community Lymphedema Monitoring: A Scoping Review. [2023]
Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital. [2021]
Pressure monitoring of multilayer inelastic bandaging and the effect of padding in breast cancer-related lymphedema patients. [2019]
A Wearable Pendant Sensor to Monitor Compliance with Range of Motion Lymphatic Health Exercise. [2020]
Correlation between bioelectrical spectroscopy and perometry in assessment of upper extremity swelling. [2023]
Attaining consensus on a core dataset for upper limb lymphoedema using the Delphi method: A foundational step in creating a clinical support system. [2023]
Local tissue water in at-risk and contralateral forearms of women with and without breast cancer treatment-related lymphedema. [2009]
Early detection and monitoring of chronic wounds using low-cost, omniphobic paper-based smart bandages. [2019]
Multifunctional skin-like electronics for quantitative, clinical monitoring of cutaneous wound healing. [2021]
Wet-Adaptive Electronic Skin. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Epidermal impedance sensing sheets for precision hydration assessment and spatial mapping. [2013]
Flexible Hybrid Electrodes for Continuous Measurement of the Local Temperature in Long-Term Wounds. [2021]